{"id":"W2554177440","doi":"10.1634/theoncologist.2016-0185","title":"Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer","year":2016,"lang":"en","type":"article","venue":"The Oncologist","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); University of Calgary; Nova Scotia Cancer Centre; BC Cancer Agency; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Palbociclib; Medicine; Exemestane; Letrozole; Everolimus; Oncology; Breast cancer; Internal medicine; Sunitinib; Adverse effect; Combination therapy; Cancer; Metastatic breast cancer; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005332085,0.0002771116,0.0004705408,0.0006359063,0.0001169226,0.000488548,0.0003327949,0.0002700628,0.003699594],"category_scores_gemma":[0.0006818209,0.00009165214,0.0005349204,0.000373345,0.0001355265,0.0004121156,0.0003305908,0.000726267,0.0008185289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002516672,"about_ca_system_score_gemma":0.0002361396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002733808,"about_ca_topic_score_gemma":0.001218482,"domain_scores_codex":[0.9997898,0.00006584721,0.00001856132,0.00002660757,0.00007910284,0.00002002758],"domain_scores_gemma":[0.9998173,0.00006168754,0.00005366242,0.00001388015,0.00003241071,0.00002107883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002628797,0.0006662683,0.002136771,0.001831234,0.0002704676,0.0002517499,0.00005890587,0.001020797,0.02730979,0.000781676,0.006014521,0.957029],"study_design_scores_gemma":[0.009023867,0.04852943,0.04980974,0.0031198,0.002840925,0.007877087,0.0003567773,0.006391482,0.06282327,0.006863641,0.8022329,0.0001310275],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2697802,0.6609833,0.02210294,0.006807298,0.001184636,0.001262457,0.001130779,0.0005975568,0.03615087],"genre_scores_gemma":[0.7282347,0.2293229,0.0253999,0.004812157,0.0009808363,0.0008467866,0.001480661,0.00008208401,0.008840029],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003699594,"threshold_uncertainty_score":0.01237637,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0302134003723064,"score_gpt":0.3549598303514997,"score_spread":0.3247464299791933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}